PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
PACS Group, Inc.NYSE: PACS
Common Stock · Q2 FY2026 · quarter ended Jun 2026
Common stock broadly unchanged from a year ago
Common stock stood at $158K at the end of Q2 FY2026, up 0.6% from a year earlier and up 0.6% from the prior quarter. Over 3 fiscal years it compounded at +6.8% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Common stock increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 157K USD
- Year-over-year change
- +1.3%
- 3-year CAGR
- +6.8%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 157K | +1.3% |
| FY2024 | 2024-12-31 | 155K | +20.2% |
| FY2023 | 2023-12-31 | 129K | +0.0% |
| FY2022 | 2022-12-31 | 129K | — |
Common Stock vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's Jun 2026 common stock of $158K is the 6th highest of the 11 companies compared; the peer median is $578K.
- Its year-over-year change of +0.6% is the 5th highest of 11, against a peer median of +0.3%.
- Common stock amounts to 0.0% of total assets for PACS, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $3.82M | -1.8% | +1.1% | 0.2% | |
| Sep 2026 | $2.49M | +0.5% | +7.9% | 0.0% | |
| Jun 2026 | $2M | +0.0% | -12.6% | 0.0% | |
| Jun 2026 | $1.2M | +0.0% | +2.9% | 0.0% | |
| Mar 2026 | $1M | +0.0% | +0.0% | 0.0% | |
| Jun 2026 | $158K | +0.6% | +6.8% | 0.0% | |
| Sep 2026 | $156K | +1.3% | +0.4% | 0.0% | |
| Mar 2026 | $137K | +0.7% | +0.2% | 0.0% | |
| Jun 2026 | $62K | +1.6% | +1.7% | 0.0% | |
| Mar 2026 | $35K | +0.0% | +6.5% | 0.0% | |
| Mar 2026 | $7K | +16.7% | -77.9% | 0.0% | |
| Peer median (excluding PACS) | $578K | +0.3% | +0.8% | 0.0% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 58.27M | 73.42M | 157.67M | 197.02M |
| Short-term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 420.12M | 600.07M | 716.52M | 702.09M |
| Inventory | 0 | 0 | 0 | 0 |
| Other Current Assets | 32.77M | 48.67M | 64.07M | 170.63M |
| Total Current Assets | 511.16M | 722.15M | 938.26M | 1.07B |
| Property, Plant & Equipment (Net) | 1.78B | 2.59B | 3.99B | 4.17B |
| Goodwill | 55.22M | 59.02M | 60.79M | 61.79M |
| Intangible Assets | 6.27M | 6.27M | 6.27M | 6.27M |
| Long-term Investments | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 113.63M | 139.96M | 252.49M | 276.96M |
| Total Non-current Assets | 1.95B | 2.79B | 4.3B | 4.51B |
| Total Assets | 2.46B | 3.51B | 5.24B | 5.58B |
| Account Payables | 110.58M | 140.95M | 175.06M | 192.23M |
| Short-term Debt | 61.36M | 16.82M | 156.85M | 4.46M |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 145.8M | 181.13M |
| Total Current Liabilities | 483.86M | 456.93M | 978.43M | 1B |
| Long-term Debt | 438.34M | 715.71M | 250.98M | 344.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 166.26M | 276.38M | 362.03M | 345.5M |
| Total Non-current Liabilities | 1.91B | 2.95B | 3.55B | 3.63B |
| Total Liabilities | 2.39B | 3.41B | 4.53B | 4.63B |
| Common Stock | 129K | 129K | 155K | 157K |
| Retained Earnings | 63.52M | 96M | 118.04M | 309.58M |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 5.01M | 5.6M | 6.14M | 5.68M |
| Total Equity | 68.65M | 101.73M | 715.69M | 952.45M |
| Total Debt | 1.93B | 2.8B | 3.5B | 3.47B |
| Net Debt | 1.87B | 2.73B | 3.34B | 3.27B |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.